Announcements Trials
Browse Landscape

Status

Completed 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 5Observational 2

Sponsor

Cancer Type

Tumor-Agnostic 2

Conditions

Pancreatic Neoplasms 2Neoplasms 2Neoplasm Metastasis 1Motor Activity 1Mobility Limitation 1Breast Neoplasms 1

Interventions

Surveys and Questionnaires 86Blood Specimen Collection 59Interviews as Topic 28Observation 15Data Collection 15Radiotherapy 13Drug Therapy 12Watchful Waiting 11Magnetic Resonance Spectroscopy 11Hematologic Tests 11Exercise 11Quality of Life 9Biopsy 8Specimen Handling 7Therapeutics 6Restraint, Physical 6Magnetic Resonance Imaging 6Focus Groups 6pembrolizumab 5Standard of Care 5Rivaroxaban 5Phlebotomy 5Nivolumab 5Lapatinib 5Immune Checkpoint Inhibitors 5Antineoplastic Agents 5atezolizumab 4apixaban 4Trastuzumab 4Patient Reported Outcome Measures 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Observational × Neoplasms × Fitness Trackers × Clear all
NCT03757182 2024-08-27

DigiSTEPS

Cedars-Sinai Medical Center

Active not recruiting
80 enrolled
Tumor-Agnostic

Neoplasm Metastasis, Neoplasms

NCT02659358 2017-09-25

Evaluating the Use of Wearable Biosensors and PROs to Assess Performance Status in Patients With Cancer

Cedars-Sinai Medical Center

Completed
37 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡